Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Medpace Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides cardiovascular, hematology, oncology, neurology, pediatrics, nephrology, and diagnostic services. Medpace Holdings serves patients worldwide.
Website: medpace.com


  • Good financial results growth rate 26.1% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (25.7%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 0.6% (LTM)
  • Share price is 245.4% higher than minimum and 3.0% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (31.7x vs 30.0x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $179.1 mln (-1.051% of cap.)

Key Financials (Download financials)

Ticker: MEDP
Share price, USD:  (0.0%)602.06
year average price 440.16  


year start price 340.18 2025-02-14

min close price 277.23 2025-04-08

max close price 620.59 2026-01-21

current price 602.06 2026-02-14
Common stocks: 28 291 000

Dividend Yield:  0.0%
FCF Yield LTM: 0.6%
EV / LTM EBITDA: 31.7x
EV / EBITDA annualized: 26.0x
Last revenue growth (y/y):  +38.6%
Last growth of EBITDA (y/y):  +44.1%
Historical revenue growth:  +24.0%
Historical growth of EBITDA:  +27.5%
EV / Sales: 7.2x
Margin (EBITDA LTM / Revenue): 22.8%

Target EV / EBITDA (hist percentile): 30.0x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 17 033
Net Debt ($m): -383
EV (Enterprise Value): 16 650
EBITDA LTM (млн $): 525
EV / LTM EBITDA: 31.7x
Price to Book: 58.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-30zacks.com

Medpace (MEDP) Declines More Than Market: Some Information for Investors

2026-01-23zacks.com

Medpace (MEDP) Stock Drops Despite Market Gains: Important Facts to Note

2026-01-14zacks.com

Why the Market Dipped But Medpace (MEDP) Gained Today

2025-12-31zacks.com

Why Medpace (MEDP) Dipped More Than Broader Market Today

2025-12-19zacks.com

Medpace (MEDP) Outperforms Broader Market: What You Need to Know

2025-11-18zacks.com

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

2025-10-29zacks.com

Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?

2025-10-28zacks.com

Best Momentum Stock to Buy for Oct. 28th

2025-10-23seekingalpha.com

Medpace Holdings, Inc. (MEDP) Q3 2025 Earnings Call Transcript

2025-10-22zacks.com

Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-23 2025-07-22 2024-10-22 2024-07-23 2024-04-23 2023-10-24 2023-07-25 2023-04-25 2022-10-25
acceptedDate 2025-10-23 16:03:09 2025-07-22 16:07:17 2025-02-11 16:03:10 2024-10-22 16:02:53 2024-07-23 16:03:54 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02 2022-02-15 16:06:17 2021-02-16 16:11:26
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 660M 603M 2 109M 533M 528M 511M 1 886M 492M 461M 434M 1 460M 384M 1 142M 926M
costOfRevenue 463M 423M 1 453M 364M 382M 356M 1 361M 359M 337M 304M 1 028M 265M 814M 647M
grossProfit 197M 180M 656M 169M 147M 155M 525M 133M 124M 130M 432M 119M 328M 279M
grossProfitRatio 0.298 0.298 0.317 0.278 0.304 0.27 0.27 0.3 0.31
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 179M 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 2M 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 48M 47M 180M 49M 41M 44M 161M 41M 39M 38M 131M 35M 108M 92M
otherExpenses 7M 7M 29M 8M -133 000 5M 26M -2M 7M 6M 22M 6M 21M 20M
operatingExpenses 55M 54M 209M 57M 41M 51M 188M 48M 46M 44M 154M 41M 130M 112M
costAndExpenses 518M 477M 1 662M 421M 423M 407M 1 549M 408M 382M 348M 1 181M 306M 944M 759M
interestIncome 2M 1M 25M 0 0 0 0 105 000 0 0 0 0 0 307 000
interestExpense 0 0 0 0 5M 4M 488 000 105 000 1M 861 000 3M 2M 105 000 0
depreciationAndAmortization 7M -7M 29M 8M 7M 7M 26M 7M 5M 6M 22M 11M 21M 20M
ebitda 150M 118M 476M 126M 112M 111M 363M 90M 84M 92M 301M 89M 220M 187M
ebitdaratio 0.227 0.195 0.237 0.213 0.217 0.183 0.181 0.212 0.233
operatingIncome 142M 126M 447M 112M 105M 104M 337M 85M 78M 86M 279M 78M 199M 167M
operatingIncomeRatio 0.215 0.209 0.211 0.199 0.204 0.172 0.17 0.199 0.203
totalOtherIncomeExpensesNet 1M -2M 29M 7M 5M 9M -1M -2M -3M -174 000 4M 4M 3M 1M
incomeBeforeTax 143M 125M 476M 119M 110M 113M 336M 83M 76M 86M 283M 82M 202M 169M
incomeBeforeTaxRatio 0.216 0.206 0.223 0.209 0.221 0.169 0.164 0.198 0.213
incomeTaxExpense 32M 34M 72M 22M 22M 10M 53M 13M 15M 13M 37M 16M 20M 23M
netIncome 111M 90M 404M 96M 88M 103M 283M 71M 61M 73M 245M 66M 182M 145M
netIncomeRatio 0.168 0.15 0.181 0.167 0.201 0.143 0.133 0.168 0.172
eps 3.95 3.16 13.06 3.11 2.85 3.32 9.2 2.3 2 2.35 7.57 2.13 5.06 4.07
epsdiluted 3.87 3.1 3.01 2.75 3.2 2.22 1.93 2.27 2.05
weightedAverageShsOut 29M 29M 31M 31M 31M 31M 31M 31M 31M 31M 32M 31M 36M 36M
weightedAverageShsOutDil 30M 30M 32M 32M 32M 32M 32M 32M 32M 32M 34M 32M 38M 38M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-11 2024-02-12 2022-12-31 2022-02-15 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 25M -488 000 -3M -105 000 307 000
ebit 447M 337M 279M 199M 167M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations 404M 283M 245M 182M 145M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 459 000
bottomLineNetIncome 404M 283M 245M 181M 145M
epsDiluted 12.63 8.88 7.28 4.81 3.84

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-23 2025-07-22 2024-10-22 2024-07-23 2024-04-23 2023-10-24 2023-07-25 2023-04-25 2022-10-25
acceptedDate 2025-10-23 16:03:09 2025-07-22 16:07:17 2025-02-11 16:03:10 2024-10-22 16:02:53 2024-07-23 16:03:54 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02 2022-02-15 16:06:17 2021-02-16 16:11:26
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 285M 46M 669M 657M 511M 407M 245M 95M 39M 47M 28M 31M 461M 278M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 285M 46M 669M 657M 511M 407M 245M 95M 39M 47M 28M 31M 461M 278M
netReceivables 373M 378M 296M 311M 301M 279M 298M 293M 275M 258M 253M 249M 186M 161M
inventory 0 0 0 0 0 0 0 1 0 0 0 0 0 0
otherCurrentAssets 79M 97M 63M 64M 61M 59M 50M 61M 65M 63M 52M 58M 0 0
totalCurrentAssets 737M 521M 1 029M 1 033M 873M 745M 594M 449M 379M 368M 334M 338M 691M 474M
propertyPlantEquipmentNet 257M 265M 252M 255M 256M 257M 265M 259M 255M 257M 249M 244M 223M 199M
goodwill 662M 662M 662M 662M 662M 662M 662M 662M 662M 662M 662M 662M 662M 662M
intangibleAssets 34M 34M 34M 35M 35M 35M 36M 36M 37M 37M 38M 39M 41M 46M
goodwillAndIntangibleAssets 696M 696M 697M 697M 697M 698M 698M 699M 699M 700M 700M 701M 704M 709M
longTermInvestments 0 0 0 0 1 0 0 0 0 0 0 0 0 0
taxAssets 37M 66M 100M 77M 75M 75M 74M 59M 52M 49M 48M 27M 25M 536 000
otherNonCurrentAssets 26M 24M 22M 23M 18M 20M 25M 21M 22M 22M 21M 19M 17M 9M
totalNonCurrentAssets 1 016M 1 051M 1 072M 1 051M 1 048M 1 051M 1 063M 1 038M 1 028M 1 028M 1 019M 991M 969M 917M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 753M 1 572M 2 101M 2 084M 1 920M 1 796M 1 657M 1 487M 1 407M 1 396M 1 352M 1 328M 1 660M 1 391M
accountPayables 27M 43M 33M 26M 27M 24M 32M 29M 34M 37M 33M 28M 26M 27M
shortTermDebt 25M 25M 23M 0 0 272M 0 265M 55M 115M 50M 140M 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 834M 809M 711M 671M 638M 617M 560M 519M 491M 466M 463M 418M 345M 256M
otherCurrentLiabilities 398M 343M 115M 344M 327M 43M 116M 36M 273M 264M 119M 235M 85M 64M
totalCurrentLiabilities 1 284M 1 220M 1 105M 1 041M 993M 957M 925M 849M 852M 882M 803M 821M 557M 440M
longTermDebt 119M 125M 0 128M 132M 136M 0 143M 139M 143M 0 139M 0 0
deferredRevenueNonCurrent 0 0 0 0 1 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 2M 2M 2M 2M 2M 2M 2M 1M 1M 1M 1M 911 000 1M 14M
otherNonCurrentLiabilities 54M 52M 43M 31M 29M 29M 28M 23M 23M 23M 23M -428M 18M 16M
totalNonCurrentLiabilities 175M 179M 171M 161M 163M 168M 173M 167M 163M 167M 163M 158M 150M 145M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 119M 125M 126M 128M 132M 136M 142M 143M 139M 143M 139M 139M 131M 115M
totalLiabilities 1 459M 1 399M 1 275M 1 203M 1 156M 1 124M 1 098M 1 016M 1 016M 1 048M 966M 979M 707M 585M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 282 000 281 000 306 000 311 000 310 000 310 000 308 000 307 000 306 000 306 000 309 000 309 000 360 000 355 000
retainedEarnings -596M -703M 8M 66M -31M -119M -222M -300M -371M -408M -360M -380M 235M 115M
accumulatedOtherComprehensiveIncomeLoss -6M -6M -15M -9M -13M -12M -10M -13M -11M -11M -12M -16M -5M -131 000
othertotalStockholdersEquity 895M 881M 825M 807M 802M 784M 773M 766M 746M
totalStockholdersEquity 294M 172M 826M 881M 764M 672M 559M 471M 391M 347M 386M 350M 953M 806M
totalEquity 294M 172M 826M 881M 764M 672M 559M 471M 391M 347M 386M 350M 953M 806M
totalLiabilitiesAndStockholdersEquity 1 753M 1 572M 2 084M 1 920M 1 796M 1 487M 1 407M 1 396M 1 328M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 753M 1 572M 2 101M 2 084M 1 920M 1 796M 1 657M 1 487M 1 407M 1 396M 1 352M 1 328M 1 660M 1 391M
totalInvestments 0 0 0 0 1 0 0 0 0 0 0 0 0 0
totalDebt 144M 150M 150M 128M 154M 136M 142M 143M 194M 258M 189M 279M 131M 115M
netDebt -141M 104M -520M -529M -357M -271M -103M 48M 155M 211M 161M 248M -330M -163M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-11 2024-02-12 2022-12-31 2022-02-15 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 291M 276M 213M 150M 138M
otherReceivables 5M 22M 40M 36M 23M
prepaids 0 0 0 43M 35M
totalPayables 33M 32M 33M 26M 27M
otherPayables 0 0 0 0 0
accruedExpenses 223M 217M 139M 101M 94M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 126M 142M 139M 131M 115M
treasuryStock -12M -12M -12M -5M -6M
additionalPaidInCapital 844M 803M 771M 728M 696M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP MEDP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-23 2025-07-22 2024-10-22 2024-07-23 2024-04-23 2023-10-24 2023-07-25 2023-04-25 2022-10-25
acceptedDate 2025-10-23 16:03:09 2025-07-22 16:07:17 2025-02-11 16:03:10 2024-10-22 16:02:53 2024-07-23 16:03:54 2024-04-23 16:02:32 2024-02-12 16:15:53 2023-10-24 16:02:38 2023-07-25 16:02:37 2023-04-25 16:03:36 2022-12-31 00:00:00 2022-10-25 16:13:02 2022-02-15 16:06:17 2021-02-16 16:11:26
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 111M 90M 404M 96M 88M 103M 283M 71M 61M 73M 245M 66M 182M 145M
depreciationAndAmortization 6M 7M 29M 8M 7M 7M 26M 7M 7M 6M 22M 6M 21M 20M
deferredIncomeTax 29M 34M -27M -2M -54 000 -865 000 -25M -8M -3M -1M -23M -687 000 -37M 527 000
stockBasedCompensation 6M 6M 26M 12M 4M 4M 21M 5M 5M 5M 21M 6M 14M 14M
changeInWorkingCapital 87M 6M 157M 29M 11M 38M 106M 33M 7M -6M 106M 27M 67M 66M
accountsReceivables 5M -80M 2M -10M -22M 19M -48M -18M 0 -4M -67M 0 -25M -6M
inventory 0 0 0 0 0 0 0 18M 0 0 0 0 0 0
accountsPayables -11M 1M -3M -576 000 5M -7M 1M -3M -2M 4M 6M -2M 2M -3M
otherWorkingCapital 93M 84M 158M 40M 28M 63M 154M 36M 9M -7M 167M 29M 90M 74M
otherNonCashItems 6M 6M 19M 6M 41M 1M 22M 7M 5M 3M 16M 5M 16M 13M
netCashProvidedByOperatingActivities 246M 149M 609M 149M 116M 153M 433M 114M 83M 80M 388M 108M 263M 259M
investmentsInPropertyPlantAndEquipment 16M -6M -37M -11M -13M -5M -37M -9M -8M -10M -37M -7M -28M -31M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -27M 93 000 51 000 81 000 8M 41 000 -21 000 10000 -8000
netCashUsedForInvestingActivites -11M -6M -10M -13M 3M -9M -8M -10M -7M
debtRepayment 0 0 0 0 0 -55M -75M -25M -110M
commonStockIssued 0 0 -8M 666 000 8M 6M 0 0 0
commonStockRepurchased -5M -541M -170M 0 0 0 -144M 0 -24M -120M -848M 0 -62M -98M
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 8M 351 000 6M 666 000 8M -49M 17M 92M 892 000
netCashUsedProvidedByFinancingActivities 3M -541M 6M 666 000 8M -49M -82M -53M -109M
effectOfForexChangesOnCash 59 000 3M -3M 1M -389 000 -1M 1M -382 000 375 000 767 000 -7M -4M -4M 666 000
netChangeInCash 239M -395M 424M 146M 104M 162M 217M 56M -8M 19M -433M -12M 184M 146M
cashAtEndOfPeriod 285M 46M 669M 657M 511M 407M 245M 95M 39M 47M 28M 31M 461M 278M
cashAtBeginningOfPeriod 46M 441M 245M 511M 407M 245M 28M 39M 47M 28M 461M 43M 278M 132M
operatingCashFlow 246M 149M 609M 149M 116M 153M 433M 114M 83M 80M 388M 108M 263M 259M
capitalExpenditure 16M -6M -37M -11M -13M -5M -37M -9M -8M -10M -37M -7M -28M -31M
freeCashFlow 262M 142M 572M 139M 104M 147M 397M 106M 74M 71M 351M 101M 235M 227M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-11 2024-02-12 2022-12-31 2022-02-15 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 8M 2M -2M -3M 126 000
netCashProvidedByInvestingActivities -28M -35M -39M -31M -31M
netDebtIssuance 0 -50M 50M 0 0
longTermNetDebtIssuance 0 0 0 0 0
shortTermNetDebtIssuance 0 -50M 50M 0 0
netStockIssuance -170M -144M -848M -62M -98M
netCommonStockIssuance -170M -144M -848M -62M -98M
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 16M 11M 22M 18M 16M
netCashProvidedByFinancingActivities -154M -183M -776M -44M -82M
incomeTaxesPaid 84M 76M 50M 56M 23M
interestPaid 171 000 3M 3M 123 000 104 000

Earning call transcript

2025 q3
2025-10-23 ET (fiscal 2025 q3)
2025 q2
2025-07-22 ET (fiscal 2025 q2)
2025 q1
2025-04-22 ET (fiscal 2025 q1)
2024 q4
2025-02-11 ET (fiscal 2024 q4)
2024 q3
2024-10-22 ET (fiscal 2024 q3)
2024 q2
2024-07-23 ET (fiscal 2024 q2)
2024 q1
2024-04-23 ET (fiscal 2024 q1)
2023 q4
2024-02-13 ET (fiscal 2023 q4)
2023 q3
2023-10-24 ET (fiscal 2023 q3)
2023 q2
2023-07-25 ET (fiscal 2023 q2)
2023 q1
2023-04-25 ET (fiscal 2023 q1)
2022 q4
2023-02-14 ET (fiscal 2022 q4)
2022 q3
2022-10-25 ET (fiscal 2022 q3)
2022 q2
2022-07-26 ET (fiscal 2022 q2)
2022 q1
2022-04-26 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-02-09 16:15 ET
Medpace reported for 2025 q4
SEC form 8
2026-02-09 16:15 ET
Medpace published news for 2025 q4
SEC form 10
2025-10-23 20:03 ET
Medpace reported for 2025 q3
SEC form 8
2025-10-22 20:15 ET
Medpace reported for 2025 q3
SEC form 8
2025-10-22 20:15 ET
Medpace published news for 2025 q3
SEC form 10
2025-07-22 20:07 ET
Medpace reported for 2025 q2
SEC form 10
2025-07-22 00:00 ET
Medpace reported for 2025 q2
SEC form 10
2025-04-22 20:02 ET
Medpace reported for 2025 q1
SEC form 10
2025-04-22 00:00 ET
Medpace reported for 2025 q1
SEC form 8
2025-03-31 20:14 ET
Medpace published news for 2024 q4
SEC form 8
2025-03-31 20:14 ET
Medpace published news for 2024 q4
SEC form 10
2025-02-11 21:03 ET
Medpace published news for 2024 q4
SEC form 10
2025-02-11 00:00 ET
Medpace published news for 2024 q4
SEC form 8
2025-02-10 16:15 ET
Medpace published news for 2024 q4
SEC form 8
2025-02-10 16:15 ET
Medpace reported for 2024 q4
SEC form 10
2024-10-22 16:02 ET
Medpace reported for 2024 q3
SEC form 10
2024-10-22 00:00 ET
Medpace published news for 2024 q3
SEC form 8
2024-10-21 16:15 ET
Medpace published news for 2024 q3
SEC form 8
2024-10-21 16:15 ET
Medpace published news for 2024 q3
SEC form 10
2024-07-23 16:03 ET
Medpace published news for 2024 q2
SEC form 10
2024-07-23 00:00 ET
Medpace published news for 2024 q2
SEC form 8
2024-07-22 16:16 ET
Medpace published news for 2024 q2
SEC form 8
2024-07-22 16:16 ET
Medpace reported for 2024 q2
SEC form 10
2024-04-23 16:02 ET
Medpace published news for 2024 q1
SEC form 10
2024-04-23 00:00 ET
Medpace published news for 2024 q1
SEC form 8
2024-04-22 16:15 ET
Medpace published news for 2024 q1
SEC form 8
2024-04-22 16:15 ET
Medpace reported for 2024 q1
SEC form 10
2024-02-13 00:00 ET
Medpace published news for 2023 q4
SEC form 8
2024-02-12 00:00 ET
Medpace published news for 2023 q4
SEC form 8
2024-02-12 00:00 ET
Medpace reported for 2023 q4
SEC form 10
2023-10-24 16:02 ET
Medpace published news for 2023 q3
SEC form 10
2023-10-24 00:00 ET
Medpace published news for 2023 q3
SEC form 8
2023-10-23 16:15 ET
Medpace reported for 2023 q3
SEC form 10
2023-07-25 00:00 ET
Medpace reported for 2023 q2
SEC form 6
2023-07-24 16:15 ET
Medpace reported for 2023 q2
SEC form 8
2023-07-24 00:00 ET
Medpace reported for 2023 q2
SEC form 10
2023-04-25 00:00 ET
Medpace published news for 2023 q1
SEC form 8
2023-04-24 00:00 ET
Medpace published news for 2023 q1
SEC form 6
2023-03-31 16:05 ET
Medpace published news for 2022 q4
SEC form 10
2023-02-14 16:07 ET
Medpace reported for 2022 q4
SEC form 10
2023-02-14 00:00 ET
Medpace reported for 2022 q4
SEC form 6
2023-02-13 16:55 ET
Medpace published news for 2022 q4
SEC form 8
2023-02-13 00:00 ET
Medpace reported for 2022 q4
SEC form 6
2023-01-18 17:00 ET
Medpace published news for 2022 q4
SEC form 6
2023-01-18 16:30 ET
Medpace published news for 2022 q4
SEC form 6
2023-01-03 16:27 ET
Medpace published news for 2022 q4
SEC form 10
2022-10-25 16:13 ET
Medpace reported for 2022 q3
SEC form 10
2022-10-25 00:00 ET
Medpace reported for 2022 q3
SEC form 6
2022-10-24 16:16 ET
Medpace published news for 2022 q3
SEC form 8
2022-10-24 00:00 ET
Medpace reported for 2022 q3
SEC form 10
2022-07-26 16:06 ET
Medpace reported for 2022 q2
SEC form 10
2022-07-26 00:00 ET
Medpace reported for 2022 q2
SEC form 6
2022-07-25 16:16 ET
Medpace published news for 2022 q2
SEC form 8
2022-07-25 00:00 ET
Medpace reported for 2022 q2
SEC form 6
2022-06-10 16:16 ET
Medpace published news for 2022 q1
SEC form 6
2022-05-26 16:31 ET
Medpace published news for 2022 q1
SEC form 6
2022-05-20 17:01 ET
Medpace published news for 2022 q1
SEC form 10
2022-04-26 16:06 ET
Medpace reported for 2022 q1
SEC form 10
2022-04-26 00:00 ET
Medpace reported for 2022 q1
SEC form 6
2022-04-25 16:17 ET
Medpace published news for 2022 q1
SEC form 8
2022-04-25 00:00 ET
Medpace reported for 2022 q1
SEC form 6
2022-04-06 16:05 ET
Medpace published news for 2022 q1
SEC form 6
2022-03-16 16:53 ET
Medpace published news for 2021 q4
SEC form 10
2022-02-15 16:06 ET
Medpace published news for 2021 q4
SEC form 10
2022-02-15 00:00 ET
Medpace published news for 2021 q4
SEC form 6
2022-02-14 16:15 ET
Medpace published news for 2021 q4
SEC form 8
2022-02-14 00:00 ET
Medpace published news for 2021 q4
SEC form 6
2021-12-29 16:40 ET
Medpace published news for 2021 q3
SEC form 10
2021-10-26 16:06 ET
Medpace published news for 2021 q3
SEC form 10
2021-10-26 00:00 ET
Medpace published news for 2021 q3
SEC form 6
2021-10-25 16:16 ET
Medpace published news for 2021 q3
SEC form 8
2021-10-25 00:00 ET
Medpace published news for 2021 q3
SEC form 6
2021-08-10 16:01 ET
Medpace published news for 2021 q2
SEC form 10
2021-07-27 16:40 ET
Medpace published news for 2021 q2
SEC form 10
2021-07-27 00:00 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-26 16:30 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-26 16:15 ET
Medpace published news for 2021 q2
SEC form 8
2021-07-26 00:00 ET
Medpace published news for 2021 q2
SEC form 6
2021-07-23 16:21 ET
Medpace published news for 2021 q2
SEC form 6
2021-06-11 16:15 ET
Medpace published news for 2021 q1
SEC form 6
2021-05-14 16:57 ET
Medpace published news for 2021 q1
SEC form 10
2021-04-27 16:05 ET
Medpace published news for 2021 q1
SEC form 10
2021-04-27 00:00 ET
Medpace published news for 2021 q1
SEC form 6
2021-04-26 16:16 ET
Medpace published news for 2021 q1
SEC form 8
2021-04-26 00:00 ET
Medpace published news for 2021 q1
SEC form 6
2021-03-30 17:22 ET
Medpace published news for 2020 q4
SEC form 6
2021-03-30 16:53 ET
Medpace published news for 2020 q4
SEC form 10
2021-02-16 16:11 ET
Medpace published news for 2020 q4
SEC form 6
2021-02-16 07:12 ET
Medpace published news for 2020 q4
SEC form 6
2020-10-30 16:05 ET
Medpace published news for 2020 q3
SEC form 10
2020-10-27 16:05 ET
Medpace published news for 2020 q3
SEC form 6
2020-10-26 16:15 ET
Medpace published news for 2020 q3